Authors: PEAK AS SUTTON BM

Citation: As. Peak et Bm. Sutton, SYSTEMIC ADVERSE-EFFECTS ASSOCIATED WITH TOPICALLY APPLIED LATANOPROST, The Annals of pharmacotherapy, 32(4), 1998, pp. 504-505

Authors: BROADHURST MJ BROWN PA LAWTON G BALLANTYNE N BORKAKOTI N BOTTOMLEY KMK COOPER MI EATHERTON AJ KILFORD IR MALSHER PJ NIXON JS LEWIS EJ SUTTON BM JOHNSON WH

Citation: Mj. Broadhurst et al., DESIGN AND SYNTHESIS OF THE CARTILAGE PROTECTIVE AGENT (CPA, RO32-3555), Bioorganic & medicinal chemistry letters, 7(17), 1997, pp. 2299-2302

Authors: WILTSHIRE HR SUTTON BM HEEPS G BETTY AM ANGUS DW MADIGAN MJ SHARP SR

Citation: Hr. Wiltshire et al., METABOLISM OF THE CALCIUM-ANTAGONIST, MIBEFRADIL (POSICOR(TM), RO-40-5967) .2. METABOLISM IN HEPATIC MICROSOMES FROM RAT, MARMOSET, CYNOMOLGUS MONKEY, RABBIT AND MAN, Xenobiotica, 27(6), 1997, pp. 539-556

Authors: WILTSHIRE HR SUTTON BM HEEPS G BETTY AM ANGUS DW HARRIS SR WORTH E WELKER HA

Citation: Hr. Wiltshire et al., METABOLISM OF THE CALCIUM-ANTAGONIST, MIBEFRADIL (POSICOR(TM), RO 40-5967) .3. COMPARATIVE PHARMACOKINETICS OF MIBEFRADIL AND ITS MAJOR METABOLITES IN RAT, MARMOSET, CYNOMOLGUS MONKEY AND MAN, Xenobiotica, 27(6), 1997, pp. 557-571

Authors: NAYLOR MA SUTTON BM NOLAN J ONEILL P FIELDEN EM ADAMS GE STRATFORD IJ

Citation: Ma. Naylor et al., RADIOLYTIC AND PHOTOCHEMICAL REDUCTION OF THE HYPOXIC CYTOTOXIN ,2-DIHYDRO-8-(4-METHYLPIPERAZINYL)-4-PHENYLIMIDAZO [1,2-A] PYRIDO [3,2-E] PYRAZINE 5-OXIDE (RB90740) AND A POTENTIAL MECHANISM FOR HYPOXIA-SELECTIVE TOXICITY, International journal of radiation oncology, biology, physics, 29(2), 1994, pp. 333-337

Authors: SUTTON BM REEVES NJ NAYLOR MA FIELDEN EM COLE S ADAMS GE STRATFORD IJ

Citation: Bm. Sutton et al., PHARMACOKINETICS, METABOLISM AND DISTRIBUTION OF ,2-DIHYDRO-8-(4-METHYLPIPERAZINYL)-4-PHENYLIMIDAZO [1,2-A] PYRIDO [3,2-E] PYRAZINE-5-OXIDEIN C3H MICE, International journal of radiation oncology, biology, physics, 29(2), 1994, pp. 339-344